Published in Urol Oncol on September 16, 2008
Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study. J Clin Oncol (2013) 2.73
Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study. J Clin Oncol (2015) 2.70
Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma. Br J Cancer (2013) 0.85
Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology. World J Urol (2015) 0.82
Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy. Diagn Pathol (2013) 0.79
Inhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferator-activated receptor-β/δ- and retinoic acid receptor-dependent mechanisms. Oncotarget (2015) 0.79
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet (2005) 3.75
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol (2000) 3.38
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. J Clin Oncol (1993) 2.42
Increasing incidence of testicular germ cell tumors among black men in the United States. J Clin Oncol (2005) 1.55
Long-term follow-up of Anglian Germ Cell Cancer Group surveillance versus patients with Stage 1 nonseminoma treated with adjuvant chemotherapy. Urology (2004) 1.05
The National Cancer Data Base report on patterns of care for testicular carcinoma, 1985-1996. Cancer (1999) 0.97
Survival of non-seminomatous germ cell cancer patients according to the IGCC classification: An update based on meta-analysis. Eur J Cancer (2006) 0.90
Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy. BJU Int (2006) 0.86
Surveillance programs for stage I nonseminomatous germ cell tumors of the testis. Urol Oncol (2006) 0.86
Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer (2004) 9.24
Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res (2006) 7.67
Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst (2004) 5.84
Utility of the SEER-Medicare data to identify chemotherapy use. Med Care (2002) 5.07
Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer (2002) 3.89
Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patients. Med Care (2006) 3.08
Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. J Natl Cancer Inst (2002) 3.04
The effectiveness of screening for prostate cancer: a nested case-control study. Arch Intern Med (2006) 2.97
Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer (2003) 2.84
Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol (2005) 2.67
Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol (2003) 2.56
Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst (2002) 2.54
Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol (2002) 2.51
Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev (2008) 2.20
Do patients consistently report comorbid conditions over time?: results from the prostate cancer outcomes study. Med Care (2005) 1.71
Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women. Breast Cancer Res Treat (2008) 1.69
Clinical trial participation and time to treatment among adolescents and young adults with cancer: does age at diagnosis or insurance make a difference? J Clin Oncol (2011) 1.64
Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000. J Clin Oncol (2006) 1.62
The effect of health insurance status on the treatment and outcomes of patients with colorectal cancer. J Surg Oncol (2014) 1.59
Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol (2003) 1.55
Treatment of de novo acute myeloid leukemia in the United States: a report from the Patterns of Care program. Leuk Lymphoma (2014) 1.53
Untreated cervical cancer in the United States. Gynecol Oncol (2005) 1.46
Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma. Gynecol Oncol (2003) 1.40
The etiology and epidemiology of merkel cell carcinoma. Curr Probl Cancer (2010) 1.39
Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer. Am J Gastroenterol (2006) 1.39
Identifying specific chemotherapeutic agents in Medicare data: a validation study. Med Care (2013) 1.36
Impact of cancer on work and education among adolescent and young adult cancer survivors. J Clin Oncol (2012) 1.35
Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev (2003) 1.34
Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999. J Natl Cancer Inst Monogr (2006) 1.30
Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. J Gen Intern Med (2003) 1.30
The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies. J Clin Oncol (2003) 1.28
Quality of life after breast cancer diagnosis and survival. J Clin Oncol (2010) 1.24
Can cancer registry data be used to study cancer treatment? Med Care (2003) 1.23
The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis. Cancer (2005) 1.22
Development of the metabolic syndrome in black and white adolescent girls: a longitudinal assessment. Pediatrics (2005) 1.20
Multiple myeloma treatment transformed: a population-based study of changes in initial management approaches in the United States. J Clin Oncol (2013) 1.19
Ductal carcinoma in situ: trends in treatment over time in the US. Breast Cancer Res Treat (2010) 1.13
Projecting SEER cancer survival rates to the US: an ecological regression approach. Cancer Causes Control (2002) 1.12
Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans. Med Care (2008) 1.07
Estimating the variance of cancer prevalence from population-based registries. Stat Methods Med Res (2006) 1.06
Patterns of care in a population-based random sample of patients diagnosed with non-Hodgkin's lymphoma. Hematol Oncol (2005) 1.04
Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease. Cancer Invest (2010) 1.03
Population-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the US. Cancer Invest (2010) 1.02
Pay for performance: rationale and potential implications for urology. J Urol (2007) 1.01
Obesity and the development of insulin resistance and impaired fasting glucose in black and white adolescent girls: a longitudinal study. Diabetes Care (2004) 1.01
Medical care in adolescents and young adult cancer survivors: what are the biggest access-related barriers? J Cancer Surviv (2014) 0.98
Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D. Medicare Medicaid Res Rev (2011) 0.98
Differences in health-related quality of life of prostate cancer patients based on stage of cancer. Psychooncology (2004) 0.97
Talking About Cancer and Meeting Peer Survivors: Social Information Needs of Adolescents and Young Adults Diagnosed with Cancer. J Adolesc Young Adult Oncol (2013) 0.97
Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide? Urology (2005) 0.95
A new method to evaluate the completeness of case ascertainment by a cancer registry. Cancer Causes Control (2008) 0.94
Patterns of colorectal cancer care in Europe, Australia, and New Zealand. J Natl Cancer Inst Monogr (2013) 0.93
Patterns of colorectal cancer care in the United States and Canada: a systematic review. J Natl Cancer Inst Monogr (2013) 0.93
Risk factors for becoming homeless among a cohort of veterans who served in the era of the Iraq and Afghanistan conflicts. Am J Public Health (2013) 0.92
Patterns of care in a population-based sample of soft tissue sarcoma patients in the United States. Cancer (2009) 0.91
Young and uninsured: Insurance patterns of recently diagnosed adolescent and young adult cancer survivors in the AYA HOPE study. Cancer (2014) 0.91
Rising incidence rates of breast carcinoma with micrometastatic lymph node involvement. J Natl Cancer Inst (2007) 0.91
Patterns of care for women with cervical cancer in the United States. Cancer (2008) 0.90
Pre-operative imaging, surgery and adjuvant therapy for women diagnosed with cancer of the corpus uteri in community practice in the United States. Gynecol Oncol (2005) 0.90
Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients. Med Care (2016) 0.90
Age disparity in the dissemination of imatinib for treating chronic myeloid leukemia. Am J Med (2010) 0.90
A population-based study of therapy and survival for patients with head and neck cancer treated in the community. Cancer (2012) 0.88
Oncotype Dx assay and breast cancer in the United States: usage and concordance with chemotherapy. Breast Cancer Res Treat (2015) 0.88
Feasibility study for collection of HER2 data by National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program central cancer registries. Cancer Epidemiol Biomarkers Prev (2010) 0.88
Pancreatic cancer in the USA: persistence of undertreatment and poor outcome. J Gastrointest Cancer (2015) 0.87
Breast cancer in men in the United States: a population-based study of diagnosis, treatment, and survival. Cancer (2010) 0.86
The development of a telemedical cancer center within the Veterans Affairs Health Care System: a report of preliminary clinical results. Telemed J E Health (2002) 0.85
Treatment of small cell lung cancer in academic and community settings: factors associated with receiving standard therapy and survival. Cancer J (2014) 0.83
Trends in the multimodality treatment of resectable colorectal liver metastases: an underutilized strategy. J Gastrointest Surg (2013) 0.83
Racial/ethnic patterns of care for pancreatic cancer. J Palliat Med (2009) 0.83
Chemotherapy in women with breast cancer. Ann Intern Med (2003) 0.82
Is mode of breast cancer detection associated with cancer treatment in the United States? Cancer (2008) 0.82
Prostate-sparing cystectomy: a review of the oncologic and functional outcomes. Contraindicated in patients with bladder cancer. Urol Oncol (2008) 0.81
Adhering to the standard of care for prostate cancer. Health Aff (Millwood) (2012) 0.80
Canadian Consensus Conference: The FDA decision on the use of 5ARIs. Can Urol Assoc J (2012) 0.80
Treatment and survival in a population-based sample of patients diagnosed with gastroesophageal adenocarcinoma. World J Gastroenterol (2008) 0.79
Magnetic resonance imaging for locating nonpalpable undescended testicles: a meta-analysis. Pediatrics (2013) 0.79
Choledocholithiasis management in rural America: health disparity or health opportunity? J Surg Res (2011) 0.77
Outcomes research in urology. World J Urol (2010) 0.77
Gastrointestinal stromal tumors: treatment patterns of a population-based sample. J Surg Oncol (2015) 0.76
Thyroid cancer presentation and treatment in the United States. Ann Surg Oncol (2014) 0.75